Loading
companiesCompany
SV Health Investors
A London and Boston healthcare investor with 30 years of history that runs biotech, medtech and growth funds, including a dementia fund. Its biotech portfolio includes cancer companies such as Bicycle Therapeutics and Xilio Therapeutics.
Overview
SV Health Investors (formerly SV Life Sciences) states on its homepage '$4.0B in historical commitments' and describes three strategies: Therapeutics, Healthcare Growth and Medtech, with offices in Boston and London. Its fund list includes SV8 Biotech Fund, SV7 Impact Medicine Fund, SV Biotech Crossover Opportunities Fund and the Dementia Discovery Funds. The portfolio page says the firm has invested 'for 30 years'. Its portfolio page shows logos rather than descriptions; oncology-relevant names include Bicycle Therapeutics (bicyclic peptide conjugates), Xilio Therapeutics (tumour-activated immunotherapies), Nimbus Therapeutics and the surgical oncology device company Onkos Surgical.
Portfolio (3)
Filter the startups table| Company | Stage | Type | Cancers | Latest round |
|---|---|---|---|---|
| Bicycle Therapeutics Cambridge, GB | Public | biotech | none on record | |
| Nimbus Therapeutics Boston, MA, US | Growth stage | biotech | Crossover 2023, $210M | |
| Xilio Therapeutics Waltham, MA, US | Public | biotech | Non-small-cell lung cancer | none on record |
Notes
top- Founding year not stated on fetched pages; omitted. Portfolio page gives names only, so oncology focus of the named companies is from general knowledge.
Similar pages
- CompanySR One
Shares Nimbus Therapeutics and the tag vc.
- CompanyAtlas Venture
Shares Nimbus Therapeutics and the tag vc.